维持性透析患者安全用药知信行现状调查及相关因素分析
魏珊, 纪鸥洋, 陈志豪, 黄泽慧, 李璞, 方均燕, 刘英莉

A prevalence study on knowledge, attitude, belief and practice of safe medication and analysis of related factors in dialysis patients
WEI Shan, JI Ouyang, CHEN Zhihao, HUANG Zehui, LI Pu, FANG Junyan, LIU Yingli
表5 维持性透析患者安全用药KAP评分多因素线性回归分析
Tab 5 Multivariable linear regression analysis of the KAP score of safe medication in maintenance dialysis patients
VariablePartial regression coefficient (β95%CIStandardized regression coefficient (β′)t valueP value
Lower limitUpper limit
Dialysis pattern
CAPD8.3913.43613.3470.2263.3420.001
Education level
Secondary education3.086‒3.5019.6730.0810.9240.356
Higher education9.1590.97817.3390.2032.2090.028
Economic level
3 000‒6 000 yuan-1.392-7.5034.719-0.037-0.4500.654
>6 000 yuan8.3091.89114.7270.2162.5550.011
Number of comorbidities-1.582-2.783-0.382-0.185-2.6010.010
Renal anemia-0.571-8.9937.851-0.009-0.1340.894
Number of medications for regulating calcium and phosphorus metabolism0.434-1.6972.5660.0290.4020.688
Number of MRPs-2.284-3.987-0.581-0.184-2.6470.009